Hosted on MSN1mon
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in conjunction with metronidazole for people aged 18 and over with complicated ...
Investing1mon
FDA approves novel antibiotic EMBLAVEO for cIAI
This marks the first approval of a fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic for this indication. AbbVie, a prominent player in the biotechnology industry with a ...